Theoretical MRI contrast model for exogenous T2 agents
Open Access
- 26 January 2007
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 57 (2) , 442-447
- https://doi.org/10.1002/mrm.21145
Abstract
The rational development of new generations of MRI contrast agents (CAs) requires a scheme for predicting contrast enhancement. Previous contrast predictions have been based largely on empirical results in specific systems. Here we present a general theoretical model for evaluating the minimum concentration of T2 CA required for satisfactory image contrast. This analytic contrast model is applicable to a wide range of T2-type agents and delivery scenarios, and requires only a few readily evaluated parameters. We demonstrated the model by predicting contrast produced by superparamagnetic ferumoxide and the iron storage protein, ferritin. We then experimentally verified the predictions using suspensions of Feridex® and ferritin in phantoms. The model was also used to compare the contrast efficacy of the metal ions in two clinically approved T1- and T2-type CAs. In the Appendix we present a numerical formalism that is useful for relating image contrast and agent concentration when gradient-echo (GRE) T-weighted (TW) pulse sequences are used. Magn Reson Med 57:442–447, 2007.Keywords
This publication has 21 references indexed in Scilit:
- In situ labeling of immune cells with iron oxide particles: An approach to detect organ rejection by cellular MRIProceedings of the National Academy of Sciences, 2006
- Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapyNature Biotechnology, 2005
- A new transgene reporter for in vivo magnetic resonance imagingNature Medicine, 2005
- Ferritin as an Endogenous MRI Reporter for Noninvasive Imaging of Gene Expression in C6 Glioma TumorsNeoplasia, 2005
- Iron oxide MR contrast agents for molecular and cellular imagingNMR in Biomedicine, 2004
- Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRIMagnetic Resonance in Medicine, 2004
- In vivo magnetic resonance imaging of transgene expressionNature Medicine, 2000
- Relaxometry and magnetometry of ferritinMagnetic Resonance in Medicine, 1998
- A model for MRI contrast enhancement using T 1 agentsProceedings of the National Academy of Sciences, 1998
- FERRITIN: STRUCTURE, GENE REGULATION, AND CELLULAR FUNCTION IN ANIMALS, PLANTS, AND MICROORGANISMSAnnual Review of Biochemistry, 1987